Top Markets
Coin of the day
Alimera Sciences, Inc. Alimera Sciences, Inc.

Alimera Sciences, Inc.

ALIM
Rankning i aktier #26669
Alimera Sciences, Inc. is a pharmaceutical company focused on developing and... Alimera Sciences, Inc. is a pharmaceutical company focused on developing and commercializing ophthalmic treatments globally, including in the United States. Its primary offering, ILUVIEN, is an intravitreal implant used to manage diabetic macular edema (DME), a severe retinal disease in individuals with diabetes that can lead to profound vision loss and blindness. Additionally, ILUVIEN helps prevent relapses of recurrent non-infectious uveitis affecting the posterior segment of the eye. The company distributes its products directly and through distributors to various healthcare entities such as physician offices, pharmacies, and hospitals. Alimera also maintains a collaboration with EyePoint Pharmaceuticals US, Inc. focused on developing and marketing insert technology. This technology is designed to deliver corticosteroids to the back of the eye for treating and preventing various human eye diseases, including diabetic macular edema. Founded in 2003, Alimera Sciences is headquartered in Alpharetta, Georgia.
Aktiekurs
$5.54
Senast synkroniserad: 2024-09-18
Marknadsvärde
$38.76M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Alimera Sciences, Inc. (ALIM)

Kategori

EPS för Alimera Sciences, Inc. (ALIM)
EPS per June 2024 TTM: $-0.28
Enligt Alimera Sciences, Inc.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $-0.28. Vid slutet av 2022 hade bolaget ett EPS på $-2.59, en ökning jämfört med EPS från 2021 som var $-0.66.
EPS-historik för Alimera Sciences, Inc. från 2006 till 2026
EPS vid slutet av varje år
År EPS Ändra
2026 (TTM) $-0.28 -64.56%
2023 $-0.79 -69.50%
2022 $-2.59 292.42%
2021 $-0.66 -36.54%
2020 $-1.04 -52.51%
2019 $-2.19 -158.40%
2018 $3.75 -176.06%
2017 $-4.93 -47.66%
2016 $-9.42 -8.90%
2015 $-10.34 -22.43%
2014 $-13.33 -45.14%
2013 $-24.30 158.24%
2012 $-9.41 -12.63%
2011 $-10.77 61.95%
2010 $-6.65 -98.48%
2009 $-437.12 -23.24%
2008 $-569.46 977.30%
2007 $-52.86 -56.02%
2006 $-120.18 0.00%
EPS för liknande företag eller konkurrenter